Cargando…

Newly developed type 1 diabetes after coronavirus disease 2019 vaccination: A case report

The vaccine for the coronavirus disease 2019 (COVID‐19) has been reported to potentially cause or worsen diabetes. A 73‐year‐old Japanese woman received two doses of Moderna COVID‐19 vaccine. Four weeks after the second vaccination, her glycemic control began to deteriorate, and 8 weeks after the se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sasaki, Hironobu, Itoh, Arata, Watanabe, Yasuhiro, Nakajima, Yuya, Saisho, Yoshifumi, Irie, Junichiro, Meguro, Shu, Itoh, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153841/ https://www.ncbi.nlm.nih.gov/pubmed/35088548 http://dx.doi.org/10.1111/jdi.13757

Ejemplares similares

Efficacy and safety of switching to insulin glargine 300 U/mL from 100 U/mL in Japanese patients with type 2 diabetes: A 12-month retrospective analysis
por: Sugiyama, Kazutoshi, et al.
Publicado: (2019)

Efficacy and Safety of Sitagliptin Added to Insulin in Japanese Patients with Type 2 Diabetes: The EDIT Randomized Trial
por: Sato, Seiji, et al.
Publicado: (2015)

Effect of single tablet of fixed-dose amlodipine and atorvastatin on blood pressure/lipid control, oxidative stress, and medication adherence in type 2 diabetic patients
por: Tanaka, Masami, et al.
Publicado: (2014)

Revisiting Regulators of Human β-cell Mass to Achieve β-cell–centric Approach Toward Type 2 Diabetes
por: Sasaki, Hironobu, et al.
Publicado: (2021)

Could the development of COVID-19 vaccine-induced type 1 diabetes be explained by a simple mechanism?
por: Sasaki, Hironobu, et al.
Publicado: (2022)

Efficacy and safety of once‐weekly exenatide after switching from twice‐daily exenatide in patients with type 2 diabetes
por: Watanabe, Yuusuke, et al.
Publicado: (2019)

Association of Maternal Factors with Perinatal Complications in Pregnancies Complicated with Diabetes: A Single-Center Retrospective Analysis
por: Endo, Sho, et al.
Publicado: (2018)

Changes in glycemic variability, gastric emptying and vascular endothelial function after switching from twice-daily to once-weekly exenatide in patients with type 2 diabetes: a subpopulation analysis of the twin-exenatide study
por: Inaishi, Jun, et al.
Publicado: (2022)

Past Obesity as well as Present Body Weight Status Is a Risk Factor for Diabetic Nephropathy
por: Meguro, Shu, et al.
Publicado: (2013)

Relationship between Stage of Diabetic Retinopathy and Pulse Wave Velocity in Japanese Patients with Type 2 Diabetes
por: Tanaka, Kumiko, et al.
Publicado: (2013)

Reduced beta cell number rather than size is a major contributor to beta cell loss in type 2 diabetes
por: Sasaki, Hironobu, et al.
Publicado: (2021)

Clinical utility of 1‐month postpartum random plasma glucose and glycated hemoglobin combined with pre‐pregnancy body mass index for detecting postpartum glucose intolerance in Japanese women with gestational diabetes
por: Sugiyama, Kazutoshi, et al.
Publicado: (2021)

Associations of birthweight and history of childhood obesity with beta cell mass in Japanese adults
por: Sasaki, Hironobu, et al.
Publicado: (2020)

Efficacy and safety of a telemedicine system in subjects with gestational diabetes mellitus (TELEGLAM): Study protocol for a randomized controlled trial
por: Aoyama, Kazuki, et al.
Publicado: (2023)

A case of hypoglycemic hemiparesis and literature review
por: Yoshino, Tetsuhiro, et al.
Publicado: (2012)

Association of visit‐to‐visit glycemic variability with risk of cardiovascular diseases in high‐risk Japanese patients with type 2 diabetes: A subanalysis of the EMPATHY trial
por: Sato, Midori, et al.
Publicado: (2021)

C-Reactive Protein, High-Molecular-Weight Adiponectin and Development of Metabolic Syndrome in the Japanese General Population: A Longitudinal Cohort Study
por: Saisho, Yoshifumi, et al.
Publicado: (2013)

Effects of Obesity and Diabetes on α- and β-Cell Mass in Surgically Resected Human Pancreas
por: Inaishi, Jun, et al.
Publicado: (2016)

Longitudinal changes in pancreatic volume and pancreatic fat with weight gain in Japanese without diabetes: An analysis using health check-up data
por: Sunouchi, Maria, et al.
Publicado: (2023)

A new normal for hypertension medicine with coronavirus disease-2019 (COVID-19): proposal from the president of the Japanese Society of Hypertension
por: Itoh, Hiroshi
Publicado: (2020)

New strategy for diagnosing abnormal glucose tolerance before 24 gestational weeks during the coronavirus disease 2019 pandemic
por: Kasuga, Yoshifumi, et al.
Publicado: (2021)

Impact of newly diagnosed diabetes on coronavirus disease 2019 severity and hyperglycemia
por: Uchihara, Masaki, et al.
Publicado: (2022)

Antepartum Oral Disposition Index as a Predictor of Glucose Intolerance Postpartum
por: Saisho, Yoshifumi, et al.
Publicado: (2012)

L-Carnitine improves gastrointestinal disorders and altered the intestinal microbiota in hemodialysis patients
por: IRIE, Junichiro, et al.
Publicado: (2016)

Barley β-glucan improves metabolic condition via short-chain fatty acids produced by gut microbial fermentation in high fat diet fed mice
por: Miyamoto, Junki, et al.
Publicado: (2018)

The short chain fatty acid receptor GPR43 regulates inflammatory signals in adipose tissue M2-type macrophages
por: Nakajima, Akira, et al.
Publicado: (2017)

CD44 variant inhibits insulin secretion in pancreatic β cells by attenuating LAT1-mediated amino acid uptake
por: Kobayashi, Nana, et al.
Publicado: (2018)

Author Correction: CD44 variant inhibits insulin secretion in pancreatic β cells by attenuating LAT1-mediated amino acid uptake
por: Kobayashi, Nana, et al.
Publicado: (2020)

Oral adsorbent AST-120 ameliorates gut environment and protects against the progression of renal impairment in CKD rats
por: Yoshifuji, Ayumi, et al.
Publicado: (2018)

Association of glucose tolerance status with pancreatic β‐ and α‐cell mass in community‐based autopsy samples of Japanese individuals: The Hisayama Study
por: Inaishi, Jun, et al.
Publicado: (2020)

Use of Diabetes Treatment Satisfaction Questionnaire in Diabetes Care: Importance of Patient-Reported Outcomes
por: Saisho, Yoshifumi
Publicado: (2018)

One-year eGFR decline rate is a good predictor of prognosis of renal failure in patients with type 2 diabetes
por: NOJIMA, Jun, et al.
Publicado: (2017)

Alogliptin benzoate for management of type 2 diabetes
por: Saisho, Yoshifumi
Publicado: (2015)

Dietary protein intake and all-cause mortality: results from The Kawasaki Aging and Wellbeing Project
por: Kurata, Hideaki, et al.
Publicado: (2023)

Importance of Beta Cell Function for the Treatment of Type 2 Diabetes
por: Saisho, Yoshifumi
Publicado: (2014)

SGLT2 Inhibitors: The Star in the Treatment of Type 2 Diabetes?
por: Saisho, Yoshifumi
Publicado: (2020)

Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetes
por: Itoh, Arata, et al.
Publicado: (2017)

Glycemic Variability and Oxidative Stress: A Link between Diabetes and Cardiovascular Disease?
por: Saisho, Yoshifumi
Publicado: (2014)

Changing the Concept of Type 2 Diabetes: Beta Cell Workload Hypothesis Revisited
por: Saisho, Yoshifumi
Publicado: (2019)

Postprandial C-Peptide to Glucose Ratio as a Marker of β Cell Function: Implication for the Management of Type 2 Diabetes
por: Saisho, Yoshifumi
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ki11oa2m5iuk4nalsnpji3g9rr